By Christian John Lillis
Infection Control Today is bringing back a much-loved feature, Bug of the Month, which helps educate readers about existing and emerging pathogens of clinical importance in healthcare facilities today.
With the specter of increased resistance to antibiotics, the scientific community is feeling pressure to find new ways to treat bacteria like Group A Streptococcus.
A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered.
Tuberculosis (TB), an ancient and notoriously difficult disease to treat, has killed millions through the course of human history; and the antibiotics that have been used to fight the disease in recent history are becoming less and less effective.
Joint replacements are among the most common elective surgeries, but around 1 in 100 patients suffer post-surgical infections, turning a routine procedure into an expensive and dangerous ordeal.
Researchers from INRA, CIRAD, CEA, the University of Montpellier, and Chicago and Vanderbilt Universities have developed an innovative method for analyzing the genome of the Wolbachia bacterium.
Autophagy, the process of recycling cellular material in the body, can help combat Salmonella and other pathogens according to researchers at the School of Life Sciences, University of Warwick who have studied how autophagy can get rid of bacteria, and prevent diseases developing.
Infections caused by drug-resistant bacteria are a global public health threat causing serious illness and even death. Strains of the bacterium Enterococcus faecium (E. faecium) are generally harmless in healthy people, but can be pathogenic in immunocompromised or severely ill patients. E.
Researchers have described a new mechanism by which influenza A viruses (IAV) alter the host immune system and make them more or less susceptible to often deadly co-occurring bacterial infections.